M. Mitka. JAMA : the journal of the American Medical Association, 307 (24):
2576-7(June 2012)6793<m:linebreak></m:linebreak>JID: 7501160; ppublish;<m:linebreak></m:linebreak>Intention to treat.
W. Holden. Drug safety : an international journal of medical toxicology and drug experience, 26 (12):
853-62(January 2003)3513<m:linebreak></m:linebreak>Relació benefici/risc.
D. Rollo, S. Machado, and M. Ceschin. Seminars in nuclear medicine, 40 (5):
332-7(September 2010)5927<m:linebreak></m:linebreak>CI: Copyright 2010; JID: 1264464; 0 (Radiopharmaceuticals); ppublish;<m:linebreak></m:linebreak>Disseny; Tipus d'estudis; RCT.
K. Wilson, and S. Hawken. Pharmacoepidemiology and drug safety, 22 (1):
108-10(January 2013)6932<br/>JID: 9208369; aheadofprint;<br/>Tipus d'estudis; Self controlled case series; Tamaño del efecto; Risc relatiu vs absolut.
N. Moore, F. Thiessard, and B. Begaud. Pharmacoepidemiology and drug safety, 14 (4):
285-6(April 2005)3925<m:linebreak></m:linebreak>Mesures d'associació.
K. Zhou, and E. Pearson. Annual review of pharmacology and toxicology, 53 (1):
299-310(January 2013)7112<m:linebreak></m:linebreak>doi: 10.1146/annurev-pharmtox-011112-140237; M3: doi: 10.1146/annurev-pharmtox-011112-140237; 08;<m:linebreak></m:linebreak>Epidemiologia genètica; Introductori.
V. Prasad, and A. Jena. JAMA : the journal of the American Medical Association, 309 (3):
241-2(January 2013)Mesures d'associació; Observacionals; Controls negatius.